Your browser doesn't support javascript.
loading
Design and synthesis of mixed micellar system for enhanced anticancer efficacy of Paclitaxel through its co-delivery with Naringin.
Jabri, Tooba; Imran, Muhammad; Aziz, Aisha; Rao, Komal; Kawish, Muhammad; Irfan, Muhammad; Malik, Muhammad Imran; Simjee, Shabana Usman; Arfan, Muhammad; Shah, Muhammad Raza.
Afiliación
  • Jabri T; a H.E.J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, Karachi University , Karachi , Pakistan.
  • Imran M; a H.E.J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, Karachi University , Karachi , Pakistan.
  • Aziz A; a H.E.J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, Karachi University , Karachi , Pakistan.
  • Rao K; a H.E.J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, Karachi University , Karachi , Pakistan.
  • Kawish M; a H.E.J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, Karachi University , Karachi , Pakistan.
  • Irfan M; a H.E.J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, Karachi University , Karachi , Pakistan.
  • Malik MI; a H.E.J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, Karachi University , Karachi , Pakistan.
  • Simjee SU; a H.E.J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, Karachi University , Karachi , Pakistan.
  • Arfan M; a H.E.J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, Karachi University , Karachi , Pakistan.
  • Shah MR; a H.E.J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, Karachi University , Karachi , Pakistan.
Drug Dev Ind Pharm ; 45(5): 703-714, 2019 May.
Article en En | MEDLINE | ID: mdl-30557053

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Portadores de Fármacos / Protocolos de Quimioterapia Combinada Antineoplásica / Paclitaxel / Flavanonas / Neoplasias Límite: Humans Idioma: En Revista: Drug Dev Ind Pharm Año: 2019 Tipo del documento: Article País de afiliación: Pakistán

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Portadores de Fármacos / Protocolos de Quimioterapia Combinada Antineoplásica / Paclitaxel / Flavanonas / Neoplasias Límite: Humans Idioma: En Revista: Drug Dev Ind Pharm Año: 2019 Tipo del documento: Article País de afiliación: Pakistán